Thomas Schneider
Neurologie · Dept. III
Memory Clinic Cohort Study
Mar 1, 2024Dementia is a clinical syndrome defined by a progressive cognitive decline interfering with a person's daily life and activities which is caused by a group of heterogenous neurodegenerative and neurovascular diseases which often overlap. Since patho...
Clinical Studies - Mar 1, 2024 - Dec 31, 2040
Ongoing
Project leader: Schneider Thomas, Felbecker Ansgar
Members: Göhl-Freyn Kristina, Schilg-Hafer Lenka
Cryptogenic Etiology in Young Adults with Stroke or Transient Ischemic Attack
Oct 2, 2023Explorierung der Charakteristika und klinischen Outcomes «junger» (18-55 J.) Patient:innen mit akutem ischämischen Schlaganfall (inkl. transient ischämischer Attacke) mit fehlender fassbarer Schöaganfallätiologie (trotz erfolgter Basisabklärung; Pati...
Clinical Studies - Oct 2, 2023 - Dec 31, 2024
Ongoing
Project leader: Dittrich Tolga, De Marchis Gian Marco
Members: Schneider Thomas
The motor side of neglect
Apr 1, 2023Motor neglect (MN), which denotes an underutilization of the contralesional limbs not explained by sensorimotor deficits, and premotor neglect (PMN), a directional disorder of movements towards or in the contralateral hemispace, are functionally disa...
Clinical Studies - Apr 1, 2023 - Dec 31, 2025
Ongoing
Project leader: Kägi Georg
Members: Schneider Thomas
Development of a non-invasive screening system for the early detection of mild cognitive impairments in older adults
Nov 1, 2020In dem geförderten Kooperationsprojekt “Development of a non-invasive screening system for the early detection of mild cognitive impairments in older adults” wird untersucht, ob ein multimodales nicht-invasives Testsystem geeignet ist, um frühe Stadi...
Clinical Studies - Nov 1, 2020 - Jul 1, 2021
Automatically Closed
Project leader: Felbecker Ansgar
Members: Schneider Thomas
A3BAD study - Analysis of amyloid aggregates in blood with atomic force microscopy as a biomarker of Alzheimer Dementia
Jun 1, 2020Background: The key neuropathological feature of Alzheimer disease (AD) is the accumulation of extracellular β-amyloid (Aβ) plaques in the brain which begins long before clinical signs of dementia. Immunotherapies targeting Aβ may prevent Aβ accumula...
Fundamental Research - Jun 1, 2020 - May 30, 2022
Automatically Closed
Project leader: Felbecker Ansgar
Members: Schneider Thomas, Nirmjaraj Peter